Anzeige
Mehr »
Login
Dienstag, 28.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
206 Leser
Artikel bewerten:
(1)

Citizen Cain: 'An Unknown Substance': Docu Short From Emmy Winner Steven Leckart & Oscar Winner Orlando Von Einsiedel Wrapping Production With Meghan McCain's Citizen McCain

Finanznachrichten News

LOS ANGELES, CALIFORNIA / ACCESS Newswire / January 22, 2025 / Oscar Winner Orlando von Einsiedel (The White Helmets, Virunga) is executive producing a short documentary directed by Emmy winner Steven Leckart (Challenger: The Final Flight) about Pulitzer Prize-winning journalist and Russian opposition politician Vladimir Kara-Murza, who was freed in August 2024 in the largest prisoner swap since the Cold War.

The film's development was spearheaded by Meghan McCain, who is executive producing through her company Citizen Cain. The film is being produced with grants provided by The New Generation Europe Foundation and executive producer Maria Logan (Anastasia), as well as the Oak Foundation. Physical production and additional financing is being provided by Los Angeles-based production company Whiskey Bear with Ben Murphy and Michael Tamburrino, producing.

Production on An Unknown Substance began in 2022, shortly after Vladimir Kara-Murza - who was poisoned in 2015 and 2017 - was imprisoned in Moscow following anti-war comments he made during a live interview on CNN. Embedded with Vladimir's wife Evgenia Kara-Murza and shot at home and in seven countries across the globe, the film captures Evgenia's tireless, emotional journey to fight for her husband's freedom and ensure his voice and message would not be silenced.

"When I first met Vladimir in 2021, I was fascinated with the idea he never stopped traveling back to Russia, despite having been poisoned there twice," said Leckart, "Initially, we intended to make a film that explored his dedication and the impact his work has on his family. We had no idea that just a few months later, Vladimir would be imprisoned and our focus would shift. When I first heard Evgenia speak publicly, I was deeply inspired to capture her journey."

"The courage of Vladimir and Evgenia Kara-Murza is nothing short of extraordinary," said McCain, "Their resilience and refusal to be silenced remind us all of the cost of freedom and the power of love and conviction. For me, this story isn't just compelling-it aligns with the values my family has always stood for. The McCain name is rooted in the fight for freedom, democracy, and the defense of human rights, and I felt a profound responsibility to help share this incredible journey."

"From the moment Steven told me about Vladimir and Evgenia, I knew I wanted to help him capture this remarkable story," says von Einsiedel. "Verite filmmaking always requires a leap

of faith that the story will reveal itself in time. The fact Steven captured what he did really is a testament to his diligence and dedication."

"We are deeply honored to collaborate with such an incredible team of filmmakers. This documentary stands as a testament to the enduring power of truth and the human spirit embodied by both Vladimir and Evgenia," said Murphy of Whiskey Bear."

"I'm so grateful for all our partners and especially for Vlad's release, which feels surreal and miraculous," said Leckart, "Ultimately, this is a love story set against the tense backdrop of a real-life political thriller - with what is now an unbelievable happy ending."

An Unknown Substance is currently in post-production.

###

For more information or press inquiries, please contact vanessa@renegadedc.com.

Contact Information

Vanessa Santos
vanessa@renegadedc.com
202-997-1289

.

SOURCE: Citizen Cain



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.